Valuation: QuidelOrtho Corporation

Market Cap 842M 729M 681M 624M 1.17B 80.18B 1.19B 7.98B 3.13B 40.19B 3.16B 3.09B 133B P/E 2026 *
-
P/E 2027 * -76.8x
Enterprise Value 3.4B 2.94B 2.75B 2.52B 4.74B 324B 4.81B 32.23B 12.65B 162B 12.77B 12.49B 536B EV / Sales 2026 *
1.34x
EV / Sales 2027 * 1.29x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day-24.72%
1 week-26.74%
Current month-26.74%
1 month-28.78%
3 months+13.75%
6 months-57.78%
Current year-56.99%
1 week 11.41
Extreme 11.41
18.04
1 month 11.41
Extreme 11.41
19.03
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.6
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
-24.72%-26.74%-48.62%-85.07% 842M
+1.18%+6.51%+28.29%-32.97% 16.86B
+4.02%-1.28%-6.98%+108.76% 1.75B
+2.21%+2.13%-29.08%+29.83% 1.01B
+2.52%+3.63%-36.96%-49.42% 679M
+3.27%+0.84%-48.14%-50.23% 548M
+1.31%+10.90%+30.91%-44.35% 523M
+4.95%+10.97%-44.20%-43.92% 417M
+3.11%+3.53%-7.97%-23.99% 384M
+6.99%+10.86%+40.28%+16.08% 364M
Average +0.48%+4.15%-12.25%-17.53% 2.34B
Weighted average by Cap. +0.78%+5.10%+15.07%-21.94%

Financials

2026 *2027 *
Net sales 2.54B 2.2B 2.05B 1.88B 3.54B 242B 3.6B 24.08B 9.45B 121B 9.54B 9.33B 401B 2.58B 2.23B 2.09B 1.91B 3.6B 246B 3.65B 24.46B 9.6B 123B 9.69B 9.48B 407B
Net income -244M -211M -197M -181M -340M -23.22B -345M -2.31B -908M -11.64B -916M -896M -38.48B -110M -95.15M -88.86M -81.51M -153M -10.47B -156M -1.04B -409M -5.25B -413M -404M -17.35B
Net Debt 2.56B 2.21B 2.07B 1.9B 3.57B 243B 3.62B 24.24B 9.52B 122B 9.61B 9.4B 403B 2.49B 2.15B 2.01B 1.85B 3.47B 237B 3.53B 23.61B 9.27B 119B 9.35B 9.15B 393B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-08-07 US$12.29 -24.72% 4,890,329
26-08-06 US$16.32 -6.72% 2,749,631
26-08-05 US$17.50 -0.48% 1,212,516
26-08-04 US$17.58 -0.73% 1,181,224
26-08-03 US$17.71 +5.61% 1,381,947
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
12.28USD
Average target price
12.00USD
Spread / Average Target
-2.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock